Stock Fundamentals

Company Information

Company Name
Terns Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US8808811074
CIK: 0001831363
CUSIP: 880881107
Currency: USD
Full Time Employees: 59
Phone: 650 525 5535
Fiscal Year End: December
IPO Date: Feb 05, 2021
Description:

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1/2 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced metabolic stability and liver distribution that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-801 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California. As of May 4, 2026, Terns Pharmaceuticals, Inc. operates as a subsidiary of Merck Sharp & Dohme LLC.

Address:

1065 East Hillsdale Boulevard, Foster City, CA, United States, 94404

Directors & Officers

Name Title Year Born
Ms. Amy L. Burroughs M.B.A. CEO & Director 1971
Mr. Scott Harris Chief Development & Operations Officer NA
Ms. Caryn Gordon McDowell J.D. Chief Legal Officer 1970
Ms. Theresa Clouser Vice President of Marketing NA
Ms. Robin Andrulevich Chief People Officer 1966
Dr. Jeffrey R. Jasper Ph.D. SVP & Senior Distinguished Research Fellow NA
Ms. Melita Sun Jung Chief Business Officer 1977
Ms. Debra Sieminski Senior Vice President of Medical Affairs NA
Mr. James Kanter Senior Vice President of CMC NA
Ms. Yasameen Qazen Pharm.D. Senior Vice President of Regulatory Affairs & Quality Assurance NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 01, 2026 Emil Kuriakose N/A Sale 942.00 $52.75 $49.69K
Mar 16, 2026 Amy L Burroughs N/A Sale 14.58K $46.71 $681.17K
Feb 17, 2026 Amy L Burroughs N/A Sale 14.58K $39.19 $571.51K
Jan 15, 2026 Amy L Burroughs N/A Sale 68.75K $37.07 $2.55M
Jan 05, 2026 Amy L Burroughs N/A Sale 71.34K $38.10 $2.72M
Jan 02, 2026 Emil Kuriakose N/A Sale 1.16K $38.57 $44.55K
Nov 04, 2025 Jill M Quigley N/A Sale 24.52K $18.00 $441.36K
Oct 01, 2025 Emil Kuriakose N/A Sale 944.00 $7.85 $7.41K
Jul 01, 2025 Emil Kuriakose N/A Sale 853.00 $4.27 $3.64K
Jun 27, 2025 Andrew Gengos N/A Purchase 10.00K $3.93 $39.30K
Jun 25, 2025 Amy L Burroughs N/A Purchase 23.31K $3.87 $90.23K
Jun 16, 2025 Andrew Gengos N/A Purchase 5.00K $3.95 $19.75K
Jun 13, 2025 Andrew Gengos N/A Purchase 10.00K $3.73 $37.30K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 8.19M Dec 31, 2025 7.09% $0.01 47.61%
Morgan Stanley - Brokerage Accounts 7.95M Dec 31, 2025 6.88% $0.02 4.70%
venBio Select Advisor LLC 5.70M Mar 31, 2026 4.93% $2.95 30.92%
Adage Capital Partners Gp LLC 5.55M Dec 31, 2025 4.80% $0.34 40.90%
Vanguard Group Inc 5.52M Dec 31, 2025 4.78% $0.00 21.14%
Vivo Capital, LLC 5.35M Dec 31, 2025 4.63% $13.96 -22.46%
Vestal Point Capital LP 4.50M Dec 31, 2025 3.90% $6.18 0.00%
HHG PLC 3.38M Dec 31, 2025 2.93% $0.06 0.00%
Citadel Advisors Llc 3.17M Dec 31, 2025 2.74% $0.02 99.24%
Capitolis Liquid Global Markets LLC 3.05M Dec 31, 2025 2.64% $0.73 0.00%
JPMorgan Chase & Co 2.87M Mar 31, 2026 2.48% $0.01 61.85%
Holocene Advisors, LP 2.78M Dec 31, 2025 2.40% $0.24 0.00%
Lord, Abbett & Co LLC 2.71M Dec 31, 2025 2.35% $0.34 0.00%
Franklin Resources Inc 2.41M Mar 31, 2026 2.09% $0.03 -11.80%
Paradigm Biocapital Advisors LP 2.22M Mar 31, 2026 1.92% $2.39 173.55%
Orbimed Advisors, LLC 2.15M Dec 31, 2025 1.86% $1.78 -71.53%
Geode Capital Management, LLC 2.10M Dec 31, 2025 1.81% $0.01 22.29%
Ameriprise Financial Inc 1.89M Dec 31, 2025 1.64% $0.02 0.00%
State Street Corp 1.78M Dec 31, 2025 1.54% $0.00 10.60%
Nearwater Capital Markets, Ltd 1.70M Dec 31, 2025 1.48% $1.18 0.00%

Shares Statistics

Shares Outstanding: 115.52M
Shares Float: 115.12M
% Insiders: 25.40%
% Institutions: 10,968.70%
Short % Float: 6.99%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 3.29M 2.84% ▲ 2.70% Mar 31, 2026
2 iShares Russell 2000 ETF 2.23M 1.93% ▲ 0.00% Apr 30, 2026
3 Lord Abbett & Co. Growth Equity- SA 1.59M 1.38% ▲ 60.93% Mar 31, 2026
4 Lord Abbett Growth Leaders I 1.59M 1.38% ▲ 0.00% Mar 31, 2026
5 American Funds SMALLCAP World A 1.42M 1.23% ▲ 34.39% Mar 31, 2026
6 HBM Healthcare Investments AG Ord 1.15M 1.00% ▲ 71.14% Dec 31, 2025
7 Candriam Eqs L Biotech C USD Cap 1.11M 0.96% ▲ 2.47% Oct 31, 2025
8 Pictet-Biotech P USD 1.08M 0.94% ▲ 0.00% Jan 31, 2026
9 Lord Abbett Growth Leaders SMA 987.23K 0.85% ▲ 0.00% Dec 31, 2025
10 Vanguard Institutional Extnd Mkt Idx Tr 961.64K 0.83% ▲ 2.50% Mar 31, 2026

Valuation Metrics

Enterprise Value: $5.10B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $6.12B
EBITDA: $-110.03M
Book Value: $8.96
Earnings/Share: $-1.03
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -9.91%
ROE (TTM): -14.23%
Revenue (TTM): $1.00M
Revenue/Share (TTM): $0.04
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 62.41x 0.00x 0.02x N/A 0.00x
2024-12-31 23.14x 0.00x 0.05x N/A 0.00x
2023-12-31 22.39x 0.00x 0.05x N/A -0.01x
2022-12-31 33.68x 0.00x 0.04x -30.38x -0.01x
2021-12-31 24.48x 0.00x 0.05x -69.06x 0.00x
2020-12-31 3.98x 0.19x 0.26x -16.72x -0.35x
2019-12-31 4.49x 0.00x 0.23x -44.83x 0.00x
2018-12-31 37.25x 0.00x 0.19x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about TERN.US!